The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for PTC Therapeutics Inc. (PTCT) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $46.08. The PTC Therapeutics Inc. has recorded 10,336 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
PTC Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $46.08 and fluctuated between $47.44 as its day high and $43.75 as its day low. The current market capitalization of PTC Therapeutics Inc. is $3.53B. A total of 0.8 million shares were traded on the day, compared to an average of 695.02K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PTCT has seen 18 BUY and 39 SELL insider trades, representing the acquisition of 223,210 and the disposition of 26,035 shares. Over the last 12 months, there were 28 BUYs and 54 SELLs from insiders. Insiders purchased 238,635 shares during that period but sold 49,545.
In the most recent transaction, Peltz Stuart Walter sold 2,320 shares of PTCT for 45.63 per share on Jan 31. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 166,962 company shares. In a previous transaction on Jan 31, Boulding Mark Elliott sold 812 shares at 45.63 per share. PTCT shares that EXEC. VP AND CLO owns now total 75,378.
Among the insiders who sold shares, Almstead Neil Gregory disposed of 630 shares on Jan 31 at a per-share price of $45.63. This resulted in the CHIEF TECHNICAL OPS OFFICER holding 63,949 shares of PTCT after the transaction. In another insider transaction, Hill Emily Luisa sold 575 shares at $45.63 per share on Jan 31. Company shares held by the CHIEF FINANCIAL OFFICER now total 46,288.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PTCT in the last 3 months, the mean price target is $51.79 with high estimates of $75.00 and low estimates of $35.00. In terms of 52-week highs and lows, PTCT has a high of $55.58 and a low of $25.01.
As of this writing, PTCT has an earnings estimate of -$1.59 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$2.32. The company reported an EPS of -$2.13 in the last quarter, which was -60.20% lower than expectations of -$1.33.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 15 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Underweight with a score of 3.83. A total of 6 analysts rated the stock as Buy while 1 rated it as Overweight while 6 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 1 thought it should be Sold.